These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 27692695)

  • 1. Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale.
    Jacobsen JPR; Krystal AD; Krishnan KRR; Caron MG
    Trends Pharmacol Sci; 2016 Nov; 37(11):933-944. PubMed ID: 27692695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SSRI Augmentation by 5-Hydroxytryptophan Slow Release: Mouse Pharmacodynamic Proof of Concept.
    Jacobsen JP; Rudder ML; Roberts W; Royer EL; Robinson TJ; Oh A; Spasojevic I; Sachs BD; Caron MG
    Neuropsychopharmacology; 2016 Aug; 41(9):2324-34. PubMed ID: 26932820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow-release delivery enhances the pharmacological properties of oral 5-hydroxytryptophan: mouse proof-of-concept.
    Jacobsen JPR; Oh A; Bangle R; Roberts WL; Royer EL; Modesto N; Windermere SA; Yi Z; Vernon R; Cajina M; Urs NM; Snyder JC; Nicholls PJ; Sachs BD; Caron MG
    Neuropsychopharmacology; 2019 Nov; 44(12):2082-2090. PubMed ID: 31035282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan.
    Wang X; Baumann MH; Dersch CM; Rothman RB
    Neuroscience; 2007 Aug; 148(1):212-20. PubMed ID: 17629409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Serotonin and Slow-Release 5-Hydroxytryptophan on Gastrointestinal Motility in a Mouse Model of Depression.
    Israelyan N; Del Colle A; Li Z; Park Y; Xing A; Jacobsen JPR; Luna RA; Jensen DD; Madra M; Saurman V; Rahim R; Latorre R; Law K; Carson W; Bunnett NW; Caron MG; Margolis KG
    Gastroenterology; 2019 Aug; 157(2):507-521.e4. PubMed ID: 31071306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral 5-hydroxytryptophan on a standardized planning task: insight into possible dopamine/serotonin interactions in the forebrain.
    Gendle MH; Young EL; Romano AC
    Hum Psychopharmacol; 2013 May; 28(3):270-3. PubMed ID: 23609610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.
    Jacobsen JP; Plenge P; Sachs BD; Pehrson AL; Cajina M; Du Y; Roberts W; Rudder ML; Dalvi P; Robinson TJ; O'Neill SP; Khoo KS; Morillo CS; Zhang X; Caron MG
    Psychopharmacology (Berl); 2014 Dec; 231(23):4527-40. PubMed ID: 24810106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice.
    Fox MA; Jensen CL; French HT; Stein AR; Huang SJ; Tolliver TJ; Murphy DL
    Psychopharmacology (Berl); 2008 Dec; 201(2):203-18. PubMed ID: 18712364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa.
    Smarius LJ; Jacobs GE; Hoeberechts-Lefrandt DH; de Kam ML; van der Post JP; de Rijk R; van Pelt J; Schoemaker RC; Zitman FG; van Gerven JM; Gijsman HJ
    J Psychopharmacol; 2008 Jun; 22(4):426-33. PubMed ID: 18308795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity of (3)H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effects.
    Larsen AK; Brennum LT; Egebjerg J; Sánchez C; Halldin C; Andersen PH
    Br J Pharmacol; 2004 Mar; 141(6):1015-23. PubMed ID: 14993096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus Calmette-Guérin vaccine induces a selective serotonin reuptake inhibitor (SSRI)-resistant depression like phenotype in mice.
    Vijaya Kumar K; Rudra A; Sreedhara MV; Siva Subramani T; Prasad DS; Das ML; Murugesan S; Yadav R; Trivedi RK; Louis JV; Li YW; Bristow LJ; Naidu PS; Vikramadithyan RK
    Brain Behav Immun; 2014 Nov; 42():204-11. PubMed ID: 25016199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants.
    Baudry A; Mouillet-Richard S; Schneider B; Launay JM; Kellermann O
    Science; 2010 Sep; 329(5998):1537-41. PubMed ID: 20847275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan.
    Jacobsen JP; Nielsen EØ; Hummel R; Redrobe JP; Mirza N; Weikop P
    Psychopharmacology (Berl); 2008 Aug; 199(2):137-50. PubMed ID: 18496675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice.
    Kreilgaard M; Smith DG; Brennum LT; Sánchez C
    Br J Pharmacol; 2008 Sep; 155(2):276-84. PubMed ID: 18552871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder.
    Meltzer H; Bastani B; Jayathilake K; Maes M
    Neuropsychopharmacology; 1997 Jul; 17(1):1-11. PubMed ID: 9194044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
    Zhao Z; Zhang HT; Bootzin E; Millan MJ; O'Donnell JM
    Neuropsychopharmacology; 2009 May; 34(6):1467-81. PubMed ID: 18923402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain.
    Nadgir SM; Malviya M
    Neurochem Res; 2008 Nov; 33(11):2250-6. PubMed ID: 18437564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan.
    Abdala-Valencia H; Berdnikovs S; McCary CA; Urick D; Mahadevia R; Marchese ME; Swartz K; Wright L; Mutlu GM; Cook-Mills JM
    Am J Physiol Lung Cell Mol Physiol; 2012 Oct; 303(8):L642-60. PubMed ID: 22842218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label trial of L-5-hydroxytryptophan in subjects with romantic stress.
    Emanuele E; Bertona M; Minoretti P; Geroldi D
    Neuro Endocrinol Lett; 2010; 31(5):663-6. PubMed ID: 21178946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.